Multiple Sclerosis Forum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Two leading multiple sclerosis (MS) experts—Nancy Sicotte, MD, director of Multiple Sclerosis and Neuroimmunology at Cedars-Sinai, and Pascal Sati, PhD, direc

(2022-05-09 | NDAQ:CLNN) Clene Reports First Quarter 2022 Financial Results and Recent Operating Highlights

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Mar 3, 2021 9:55am Novartis presented positive study data at the sixth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum from nurses and patients using its Kesimpta auto-injector pen for MS. (Novartis) Novartis nabbed FDA approval for Kesimpta to treat multiple sclerosis last year, but now it’s getting the thumbs-up from MS patients and nurses. Novartis presented study data at the sixth annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum in late February showing 84% preferred Kesimpta’s self-administration injector pen over riv...

Senior Editor Women with MS who continue their disease-modifying therapy, or DMT, throughout pregnancy have lower hospitalization costs and use, compared to those who discontinued their therapy. That finding comes from a retrospective study conducted by Walgreens in collaboration with AllianceRx Walgreens Prime to understand how non-adherence to these women’s DMTs would impact healthcare cost and utilization over a two-year period. The researchers presented the findings on Feb. 26 at the virtual Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2021. M...